Quick Answer
UTAH MEDICAL PRODUCTS INC reported Total Assets of $122.54 million for the year ending 2025.
- UTAH MEDICAL PRODUCTS INC showed an increase of +0.0% in Total Assets from 2024 to 2025.
- This data is from UTAH MEDICAL PRODUCTS INC's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $80.77 million | Q3 2011: $79.06 million | Q1 2012: $79.97 million | Q2 2012: $76.88 million | Q3 2012: $78.80 million | Q1 2013: $76.36 million | Q2 2013: $76.43 million | Q3 2013: $80.60 million | Q1 2014: $82.89 million | Q2 2014: $84.29 million | Q3 2014: $82.29 million | Q1 2015: $75.38 million | Q2 2015: $79.93 million | Q3 2015: $80.16 million | Q1 2016: $83.21 million | Q2 2016: $81.04 million | Q3 2016: $82.82 million | Q1 2017: $82.17 million | Q2 2017: $85.95 million | Q3 2017: $90.68 million | Q1 2018: $97.19 million | Q2 2018: $97.04 million | Q3 2018: $99.15 million | Q1 2019: $105.05 million | Q2 2019: $103.36 million | Q3 2019: $104.09 million | Q1 2020: $103.19 million | Q2 2020: $103.55 million | Q3 2020: $107.07 million | Q1 2021: $114.39 million | Q2 2021: $116.79 million | Q3 2021: $119.75 million | Q1 2022: $119.80 million | Q2 2022: $116.15 million | Q3 2022: $118.41 million | Q1 2023: $127.77 million | Q2 2023: $130.48 million | Q3 2023: $131.24 million | Q1 2024: $135.44 million | Q2 2024: $130.03 million | Q3 2024: $129.69 million | Q1 2025: $122.52 million | Q2 2025: $120.80 million | Q3 2025: $121.98 million.
- Over the full 16 years of available data (2010 to 2025), UTAH MEDICAL PRODUCTS INC's Total Assets has grown by 197.2%.
- Historical annual values: Fiscal year 2025: $122.54 million | Fiscal year 2024: $122.54 million | Fiscal year 2023: $135.46 million | Fiscal year 2022: $123.87 million | Fiscal year 2021: $115.64 million | Fiscal year 2020: $111.75 million | Fiscal year 2019: $109.79 million | Fiscal year 2018: $99.77 million | Fiscal year 2017: $92.75 million | Fiscal year 2016: $76.19 million | Fiscal year 2015: $79.18 million | Fiscal year 2014: $81.08 million | Fiscal year 2013: $80.71 million | Fiscal year 2012: $76.94 million | Fiscal year 2011: $76.39 million | Fiscal year 2010: $41.24 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: